United European Gastroenterology (UEG) week, Vienna, Austria: “Crohn’s disease and ulcerative colitis exhibit pre-diagnostic antibody signatures with shared and divergent changes towards disease onset ” (oral presentation in Opening Plenary session UEG 2024)
United European Gastroenterology (UEG) week, Vienna, Austria: “Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn’s disease and chronic fatigue syndrome ” (oral presentation)
United European Gastroenterology (UEG) week, Vienna, Austria: “Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease” (moderated poster presentation)
Mount Sinai IBD Retreat, New York, United States: “Distinct plasma proteomic biomarkers associate with disease progression in patients with Inflammatory Bowel Diseases” (oral presentation)
Post-DDW symposium, Amsterdam, the Netherlands: “IBD highlights van de Digestive Disease Week 2024” (invited speaker)
International Student Congress Of (bio)Medical Sciences (ISCOMS) Speed Keynote Lecture, Groningen, the Netherlands: “Multimodal biomarker discovery in IBD and beyond” (invited speaker)
Digestive Disease Week (DDW), Washington, United States: “Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease” (poster presentation)
Digestive Disease Week (DDW), Washington, United States: “Mild Crohn’s disease is characterized by a unique serum metabolomic signature” (poster presentation)
Digestive Disease Week (DDW), Washington, United States: “Changes in systemic antibody epitope repertoires from preclinical to established Inflammatory Bowel Disease” (oral presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Stockholm, Sweden: “Changes in systemic antibody epitope repertoires from preclinical to established Inflammatory Bowel Disease” (oral presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Stockholm, Sweden: “Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease” (oral presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Stockholm, Sweden: “Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn’s Disease and chronic fatigue syndrome” (oral presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Stockholm, Sweden: “Mild Crohn’s disease is characterized by a unique serum metabolomic signature” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Stockholm, Sweden: “Distinct plasma proteomic biomarkers associate with disease progression in patients with Inflammatory Bowel Diseases” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Stockholm, Sweden: “Anti-TNF exposure is associated with an increased risk of urgent and one-year colectomy in Acute Severe Ulcerative Colitis” (poster presentation)
2023
Digestive Disease Week (DDW), Chicago, United States: “Redox-modulating therapeutics in IBD” (invited speaker)
Digestive Disease Days (DDD), VNederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease” (oral presentation)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “Primair scleroserene cholangitis en IBD: van pathofysiologie naar klinische praktijk” (invited speaker)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease” (oral presentation)
2022
Young-Initiative on Crohn’s and Colitis (Young-ICC) Najaarssymposium, Utrecht, the Netherlands: “Het darmmicrobioom en IBD” (invited speaker)
United European Gastroenterology (UEG) week, Vienna, Austria: “Serological biomarkers of type I, III, and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn’s disease” (moderated poster presentation)
United European Gastroenterology (UEG) week, Vienna, Austria: “Proteomic analyses do not reveal subclinical inflammation in fatigued patients with quiescent inflammatory bowel disease” (poster presentation)
United European Gastroenterology (UEG) week, Vienna, Austria: “Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with inflammatory bowel diseases” (poster presentation)
United European Gastroenterology (UEG) week, Vienna, Austria: “Distinct mucosal host-microbe interactions in inflammatory bowel disease” (poster presentation)
United European Gastroenterology (UEG) week, Vienna, Austria: “In-depth characterization of the serum antibody epitope repertoire in inflammatory bowel disease by high-throughput phage-display immunoprecipitation sequencing” (moderated poster presentation)
Medical University of Vienna, Vogl Lab, Vienna, Austria: “Multimodal discovery of biomarker signatures in IBD and beyond” (invited speaker)
International Society for Antioxidants, Nutrition and Health (ISANH), Paris, France: “Personalized redox medicine in inflammatory bowel disease” (invited speaker)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “Patients with Inflammatory Bowel Disease show IgG immune responses towards disease-associated small intestinal bacteria” (oral presentation)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “Mucosal microbiota modulate host intestinal immune signatures in inflammatory bowel disease” (oral presentation)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “In-depth characterization of the serum antibody epitope repertoire in inflammatory bowel disease by high-throughput phage-displayed immunoprecipitation sequencing” (oral presentation)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “Proteomic analyses do not reveal subclinical inflammation in fatigued patients with quiescent inflammatory bowel disease” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “In-depth characterization of the serum antibody epitope repertoire in inflammatory bowel disease by high-throughput phage-displayed immunoprecipitation sequencing” (oral presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “Proteomic analyses do not reveal subclinical inflammation in fatigued patients with quiescent inflammatory bowel disease” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “Patients with Inflammatory Bowel Disease show IgG immune responses towards disease-associated small intestinal bacteria” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “Mucosal microbiota modulate host intestinal immune signatures in inflammatory bowel disease” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with inflammatory bowel disease” (poster presentation)
2021
United European Gastroenterology (UEG) week, Vienna, Austria: “The effect of phenotype and genotype on the plasma proteome in patients with inflammatory bowel disease” (poster presentation)
United European Gastroenterology (UEG) week, Vienna, Austria: “Type IV collagen formation/degradation ratio predicts response to infliximab induction therapy in patients with ulcerative colitis” (poster presentation)
United European Gastroenterology (UEG) week, Vienna, Austria: “Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn’s disease” (poster presentation)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn’s disease” (oral presentation)
International Society for Antioxidants, Nutrition and Health (ISANH), Paris, France: “N-Acetylcysteine and Hydrogen Sulfide: A Convenient Rationale for Coronavirus Disease 2019 (COVID-19)” (invited speaker)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “Type IV collagen formation/degradation ratio predicts response to infliximab induction therapy in patients with ulcerative colitis” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “Type I, III and IV collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn’s disease” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “The effect of phenotype and genotype on the plasma proteome in patients with inflammatory bowel disease” (oral presentation)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “The effect of phenotype and genotype on the plasma proteome in patients with inflammatory bowel disease” (oral presentation)
2020
International Society for Antioxidants, Nutrition and Health (ISANH), Paris, France: “Systemic Oxidative Stress, Microbiota, and Redox-Modulating Therapeutics in Inflammatory Bowel Disease” (invited speaker)
United European Gastroenterology (UEG) week, Amsterdam, the Netherlands: “Systemic iron deficiency and intestinal inflammation control gut mucosal regulation of hypoxia in inflammatory bowel disease” (oral presentation)
2019
United European Gastroenterology (UEG) week, Barcelona, Spain: “Levels of serum free thiols are superior to fecal calprotectin in predicting endoscopic disease activity in inflammatory bowel disease” (poster presentation)
United European Gastroenterology (UEG) week, Barcelona, Spain: “Riboflavin suppresses inflammation and attenuates Crohn’s disease symptoms (RISE-UP study)” (poster presentation)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “Riboflavin supplementation in patients with Crohn’s disease [the RISE-UP study]” (oral presentation)
Digestive Disease Days (DDD), Nederlandse Vereniging voor Gastroenterologie (NVGE), Veldhoven, the Netherlands: “Serum free thiols are superior to fecal calprotectin in reflecting endoscopic disease activity in inflammatory bowel disease” (oral presentation)
International Society for Antioxidants, Nutrition and Health (ISANH), Paris, France: “Levels of serum free thiols are superior to fecal calprotectin in predicting endoscopic disease activity in inflammatory bowel disease” (oral presentation)
Digestive Disease Week (DDW), San Diego, United States: “A combined set of four serum inflammatory biomarkers reliably predicts endoscopic disease activity in inflammatory bowel disease” (poster presentation)
European Crohn’s and Colitis Organisation (ECCO) congress, Copenhagen, Denmark: “A combined set of four serum inflammatory biomarkers reliably predicts endoscopic disease activity in inflammatory bowel disease” (poster presentation)